| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 257, Issue 5 1613-H1623, Copyright © 1989 by American Physiological Society
ARTICLES |
F. L. Minnear, M. A. DeMichele, D. G. Moon, C. L. Rieder and J. W. Fenton 2nd
Department of Physiology, Albany Medical College 12208.
The ability of the beta-adrenergic agonist, isoproterenol, to attenuate the thrombin-induced increase in endothelial permeability was examined by measuring 125I-labeled albumin clearance across endothelial cell monolayers. Bovine pulmonary artery endothelial cells (CCL-209) were grown to confluence on gelatinized, polycarbonate micropore filters and mounted on modified Boyden chambers with Dulbecco's modified Eagle's medium (DMEM) and 0.5% bovine serum albumin. alpha-Thrombin at 0.2 nM to 2 microM produced a dose-related increase (P less than 0.01) in 125I-labeled albumin clearance from the DMEM control value. Light and electron microscopy revealed that the thrombin-induced increase in permeability correlated with changes in cell shape and rearrangement of filamentous actin. Coincubation of 2 microM isoproterenol with 2 microM alpha-thrombin reduced (P less than 0.01) the thrombin-induced increase in albumin clearance and the observed morphological changes. This attenuation was not caused by inhibition of thrombin's enzymatically active site, since isoproterenol did not impair thrombin's fibrinogen clotting activity nor its amidolytic cleavage of an artificial substrate (Spectrozyme-TH). Coincubation of 20 microM propranolol, a beta-adrenergic antagonist, with 2 microM isoproterenol and thrombin blocked the permeability-decreasing effect of isoproterenol. Both 2 microM isoproterenol and 2 pM alpha-thrombin alone decreased (P less than 0.01) albumin clearance below the DMEM control value. These results suggest that isoproterenol can reduce the thrombin-induced increase in endothelial permeability in vitro by directly maintaining actin filaments and the shape of endothelial cells.
This article has been cited by other articles:
|
|
 |
|
  M. Xu, C. L. Waters, C. Hu, R. B. Wysolmerski, P. A. Vincent, and F. L. Minnear Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1309 - C1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Su, L. Robriquet, H. G. Folkesson, and M. A. Matthay Protective effect of endogenous beta-adrenergic tone on lung fluid balance in acute bacterial pneumonia in mice Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L769 - L776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Minnear, L. Zhu, and P. He Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H840 - H844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bindewald, D. Gunduz, F. Hartel, S. C. Peters, C. Rodewald, S. Nau, M. Schafer, J. Neumann, H. M. Piper, and T. Noll Opposite effect of cAMP signaling in endothelial barriers of different origin Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1246 - C1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Gainor, C. A. Morton, J. T. Roberts, P. A. Vincent, and F. L. Minnear Platelet-conditioned medium increases endothelial electrical resistance independently of cAMP/PKA and cGMP/PKG Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1992 - H2001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Farmer, S. G. Bernier, A. Lepage, G. Guillemette, D. Regoli, and P. Sirois Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L732 - L738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Waypa, C. A. Morton, P. A. Vincent, J. R. Mahoney Jr., W. K. Johnston III, and F. L. Minnear Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production J Appl Physiol, March 1, 2000; 88(3): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lum, H. A. Jaffe, I. T. Schulz, A. Masood, A. RayChaudhury, and R. D. Green Expression of PKA inhibitor (PKI) gene abolishes cAMPmediated protection to endothelial barrier dysfunction Am J Physiol Cell Physiol, September 1, 1999; 277(3): C580 - C588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Merkle, L. M. Wilson, and A. L. Baldwin Acute blood stasis reduces interstitial uptake of albumin from intestinal microcirculatory networks Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H600 - H608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Patil, J. E. Kaplan, and F. L. Minnear Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2304 - H2311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. OCHOA, G. WAYPA, J. R. MAHONEY Jr., L. RODRIGUEZ, and F. L. MINNEAR Contrasting Effects of Hypochlorous Acid and Hydrogen Peroxide on Endothelial Permeability . Prevention with cAMP Drugs Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1247 - 1255. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
